VivoSeq
Other

Platelet Function

0

Pipeline Programs

2

Active Trials

4

Companies Involved

Platelet Function is an early-stage landscape with 0 programs across 4 companies. The most active players are Merck & Co., Boehringer Ingelheim, Javelin Pharmaceuticals.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

6/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

33

clinical trials

Completed26 · 79%
Unknown status3 · 9%
Withdrawn2 · 6%
Recruiting2 · 6%

Trial Activity

33 trials

Depression, Epinephrine, and Platelet Function
Completed·EEmory University·Phase 4·NCT00166114·40 enrolled
Platelet Function in Hemodialysis Patient
Completed·CCHU de Reims·N/A·NCT02792283·100 enrolled
Effects of Fish Oil on Platelet Function and Coagulation
Completed··N/A·NCT03048981·12 enrolled
Effects of Pioglitazone on Platelet Function
Completed·UUniversity of Rochester·Phase 2·NCT00861341·40 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)